leisure time -WSS

leisure time

author：knowledge 2025-09-28 02:31:13 - browse：9

AI skin cancer detector, dermasensor. -- health tech coverage from STAT — Around 5 million skin cancers are diagnosed each year in the United States. Skin cancer is common, but it’s also not that deadly when caught early. Courtesy DermaSensor

The Food and Drug Administration cleared an AI-powered device for detecting skin cancer on Wednesday, giving primary care physicians a new way to evaluate troubling skin spots.

Around 5 million skin cancers are diagnosed each year in the United States. Skin cancer is common, but most types are not that deadly when caught early.

The device, developed by a small company called DermaSensor, is handheld and uses light to examine suspicious moles on a cellular level. It will be marketed specifically for primary care physicians to use in routine check-ups in patients aged 40 and above.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Activists slam private health insurers over coverage restrictions
Next article： How to bring more disabled researchers into academia

WSS

The future of Biogen: Pragmatism, ‘moonshots,’ and no Twinkies

Readout Newsletter: AstraZeneca's CEO, Roivant's $5 billion deal

Readout Newsletter: Acadia, Eli Lilly, Madrigal Pharma updates

Merck, Daiichi strike cancer drug pact worth up to $22 billion

Change Healthcare cyberattack prompts Medicare loan program

Results on Novartis prostate cancer therapy could expand its use

focus

leisure time

Wikipedia

Sports medicine is finally prioritizing gender equality

STAT Summit: The economic case for universal basic health care

What does generative AI mean for health care? We asked experts

STAT Summit: The economic case for universal basic health care

Malaria cases in Florida and Texas: Here’s what you need to know

The future of Biogen: Pragmatism, ‘moonshots,’ and no Twinkies

The high cost of giving birth even with insurance

FDA clears Verve to begin U.S. study of gene

New air purifier tech could be key to improving indoor air quality

A deep dive into Applied Therapeutics’ data, and questions on Cassava

entertainment

Study on Amgen’s bispecific immunotherapy produces positive data

Health tech investors get more selective as pandemic boom fades

In surprise move, FDA calls for advisory committee on Lilly's Alzheimer's drug

Headspace, Meta partner to launch VR meditation app for Quest

Roivant's CEO is a star, but biotech's black hole persists

In surprise move, FDA calls for advisory committee on Lilly's Alzheimer's drug

focus

focus

focus

hotspot